Publications of Christoph W. Turck
All genres
Journal Article (167)
41.
Journal Article
1047, pp. 131 - 140 (2017)
MALDI imaging mass spectrometry Analysis - A new approach for protein mapping in multiple sclerosis brain lesions. JOURNAL OF CHROMATOGRAPHY B: ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES 42.
Journal Article
151, pp. 97 - 105 (2017)
Peptidomic analysis of the anterior temporal lobe and corpus callosum from schizophrenia patients. JOURNAL OF PROTEOMICS 43.
Journal Article
7, e1078 (2017)
Delineation of molecular pathway activities of the chronic antidepressant treatment response suggests important roles for glutamatergic and ubiquitin-proteasome systems. TRANSLATIONAL PSYCHIATRY 44.
Journal Article
10, 272 (2017)
Proteomic Differences in Blood Plasma Associated with Antidepressant Treatment Response. FRONTIERS IN MOLECULAR NEUROSCIENCE 45.
Journal Article
7, 15788 (2017)
Ketamine's antidepressant effect is mediated by energy metabolism and antioxidant defense system. SCIENTIFIC REPORTS 46.
Journal Article
6, 35317 (2016)
Purine and pyrimidine metabolism: Convergent evidence on chronic antidepressant treatment response in mice and humans. SCIENTIFIC REPORTS 47.
Journal Article
214 (2), pp. 181 - 195 (2016)
Different cAMP sources are critically involved in G protein-coupled receptor CRHR1 signaling. JOURNAL OF CELL BIOLOGY 48.
Journal Article
41 (7), pp. 1751 - 1758 (2016)
Selective Mitochondrial Targeting Exerts Anxiolytic Effects In Vivo. NEUROPSYCHOPHARMACOLOGY 49.
Journal Article
76, pp. 74 - 83 (2016)
Fluoxetine treatment prevents the inflammatory response in a mouse model of posttraumatic stress disorder. JOURNAL OF PSYCHIATRIC RESEARCH 50.
Journal Article
10, 52 (2016)
Effect of MK-801 and Clozapine on the Proteome of Cultured Human Oligodendrocytes. FRONTIERS IN CELLULAR NEUROSCIENCE 51.
Journal Article
21 (2), pp. 277 - 289 (2016)
FKBP51 inhibits GSK3 beta and augments the effects of distinct psychotropic medications. MOLECULAR PSYCHIATRY 52.
Journal Article
2 (1), pp. 46 - 59 (2016)
Fluoxetine Treatment Rescues Energy Metabolism Pathway Alterations in a Posttraumatic Stress Disorder Mouse Model. Molecular neuropsychiatry 53.
Journal Article
26 (7), pp. 1110 - 8 (2016)
Peripheral fibroblast metabolic pathway alterations in juvenile rhesus monkeys undergoing long-term fluoxetine administration. European neuropsychopharmacology: the journal of the European College of Neuropsychopharmacology 54.
Journal Article
10 (12), pp. 1269 - 1272 (2016)
Stable isotope metabolic labeling suggests differential turnover of the DPYSL protein family. Proteomics. Clinical applications 55.
Journal Article
10 (12), pp. 1269 - 1272 (2016)
Stable isotope metabolic labeling suggests differential turnover of the DPYSL protein family. SI 56.
Journal Article
9 (9-10 SI), pp. 817 - 831 (2015)
The protein interactome of collapsin response mediator protein-2 (CRMP2/DPYSL2) reveals novel partner proteins in brain tissue. PROTEOMICS CLINICAL APPLICATIONS 57.
Journal Article
20 (9), pp. 1108 - 1119 (2015)
Peripheral brain-derived neurotrophic factor in schizophrenia and the role of antipsychotics: meta-analysis and implications. MOLECULAR PSYCHIATRY 58.
Journal Article
9, 180 (2015)
MK-801 treatment affects glycolysis in oligodendrocytes more than in astrocytes and neuronal cells: insights for schizophrenia. FRONTIERS IN CELLULAR NEUROSCIENCE 59.
Journal Article
40 (5), pp. 1222 - 1233 (2015)
Homer1/mGluR5 Activity Moderates Vulnerability to Chronic Social Stress. NEUROPSYCHOPHARMACOLOGY 60.
Journal Article
18 (2), pp. 239 - 251 (2015)
Neddylation inhibition impairs spine development, destabilizes synapses and deteriorates cognition. NATURE NEUROSCIENCE